Mark Wilterding | SVP, IR and Treasurer |
Michael Mussallem | Chairman and CEO |
Scott Ullem | CFO |
Bernard Zovighian | President |
Larry Wood | Group President, TAVR and Surgical Structural Hear |
Daveen Chopra | Global Leader of TMTT |
Larry Biegelsen | Wells Fargo |
Robbie Marcus | JPMorgan |
Vijay Kumar | Evercore |
Joanne Wuensch | Citibank |
Travis Steed | Bank of America |
Danielle Antalffy | UBS |
Richard Newitter | Truist |
Matt Miksic | Barclays |
Cecilia Furlong | Morgan Stanley |
Josh Jennings | TD Cowen |
Greetings, and welcome to the Edwards Lifesciences' First Quarter 2023 Earnings Results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded.
I will now turn the conference over to our host, Mark Wilterding, Senior Vice President, Investor Relations and Treasurer.